Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats (original) (raw)
Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions
Ignacio Madrazo
Spinal cord, 2008
View PDFchevron_right
Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury
Antigona Ulndreaj
F1000Research
View PDFchevron_right
Development of Protective Autoimmunity by Immunization with a Neural-Derived Peptide Is Ineffective in Severe Spinal Cord Injury
Susana Martiñón
PLoS ONE, 2012
View PDFchevron_right
A review of published reports on neuroprotection in spinal cord injury
Alexandru Vlad
Spinal Cord, 2009
View PDFchevron_right
Long-term production of BDNF and NT-3 induced by A91-immunization after spinal cord injury
Susana Martiñón
BMC Neuroscience, 2016
View PDFchevron_right
Therapeutic Window for Combination Therapy of A91 Peptide and Glutathione Allows Delayed Treatment After Spinal Cord Injury
Adriana Flores
Basic & Clinical Pharmacology & Toxicology, 2013
View PDFchevron_right
Neuroprotective Agents as an Adjuvant Treatment in Patients With Acute Spinal Cord Injuries
Jefferson W Daniel
Clinical spine surgery, 2019
View PDFchevron_right
Neuroprotection and secondary damage following spinal cord injury: concepts and methods
Wolfram Tetzlaff
Neuroscience Letters, 2017
View PDFchevron_right
Immunization with a Neural-Derived Peptide Protects the Spinal Cord from Apoptosis after Traumatic Injury
Ana Fernández-presas, Ibarra Arias Jose Juan, Susana Martiñón
BioMed Research International, 2013
View PDFchevron_right
Trends in Neuroprotective Strategies after Spinal Cord Injury: State of the Art
Roxana Rodríguez Barrera
Neuroprotection - New Approaches and Prospects [Working Title], 2019
View PDFchevron_right
Pharmacologic Neuroprotection in Patients with Spinal Cord Injury and the Efficacy of Early Decompressive Surgery
Kornelis Poelstra
Topics in Spinal Cord Injury Rehabilitation, 2006
View PDFchevron_right
Pharmacological Neuroprotective Therapy for Acute Spinal Cord Injury: State of the Art
Susana Martiñón
Mini-Reviews in Medicinal Chemistry, 2008
View PDFchevron_right
A Systematic Review of Non-Invasive Pharmacologic Neuroprotective Treatments for Acute Spinal Cord Injury
Wolfram Tetzlaff
Journal of Neurotrauma, 2010
View PDFchevron_right
Use of Cells, Supplements and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update
Ernesto Doncel-pérez
View PDFchevron_right
Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury
Gevick Safarians
International Journal of Molecular Sciences
View PDFchevron_right
The Severity of Spinal Cord Injury Determines the Inflammatory Gene Expression Pattern after Immunization with Neural-Derived Peptides
Roxana Rodríguez Barrera
Journal of molecular neuroscience : MN, 2018
View PDFchevron_right
Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury
Frank Hamers
Experimental Neurology, 2006
View PDFchevron_right
The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats
Antonio Ibarra
European Journal of Neuroscience, 2004
View PDFchevron_right
Traumatic spinal cord injury: current concepts and treatment update
Gisele Silva
Arquivos de Neuro-Psiquiatria, 2017
View PDFchevron_right
Strategies to Promote Neural Repair and Regeneration After Spinal Cord Injury
Wolfram Tetzlaff
Spine, 2005
View PDFchevron_right
Therapeutic Strategies for Spinal Cord Injury
Pavla Jendelova
International Journal of Molecular Sciences
View PDFchevron_right
Passive or Active Immunization with Myelin Basic Protein Promotes Recovery from Spinal Cord Contusion
Eugenia Agranov
The Journal of Neuroscience the Official Journal of the Society For Neuroscience, 2000
View PDFchevron_right
Neuroprotection and acute spinal cord injury: A reappraisal
Edward Hall
Neurorx, 2004
View PDFchevron_right
The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries
Nuno Alegrete
Revista Brasileira De Ortopedia, 2015
View PDFchevron_right
Effects of methylprednisolone and MK-801 on functional recovery after experimental chronic spinal cord injury
Siavash Haghighi
Spinal Cord, 2000
View PDFchevron_right
Review of recently documented clinical neuroprotective and cellular treatment for spinal cord injury: an analysis of outcomes
Hooshang Saberi
Journal of Neurorestoratology, 2013
View PDFchevron_right
Pathophysiology and pharmacologic treatment of acute spinal cord injury
Wolfram Tetzlaff
Spine Journal, 2004
View PDFchevron_right